default author photo

Mark S. Graham

King’s College London - School of Biomedical Engineering & Imaging Sciences

Strand

London, WC2R 2LS

United Kingdom

SCHOLARLY PAPERS

1

DOWNLOADS

895

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Vaccine after Effects and Post-Vaccine Infection in a Real World Setting: Results from the COVID Symptom Study App

Number of pages: 26 Posted: 04 Mar 2021
King's College London - Department of Twin Research and Genetic Epidemiology, King’s College London - School of Biomedical Engineering & Imaging Sciences, Zoe Global Limited, Zoe Global Limited, Zoe Global Limited, King’s College London - Department of Twin Research and Genetic Epidemiology, University College London, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Massachusetts General Hospital - Center for Genomic Medicine, King’s College London - School of Biomedical Engineering & Imaging Sciences, King’s College London, King’s College London - School of Biomedical Engineering & Imaging Sciences, King’s College London - School of Biomedical Engineering & Imaging Sciences, King’s College London - School of Biomedical Engineering & Imaging Sciences, King’s College London - School of Biomedical Engineering & Imaging Sciences, Harvard University - Harvard Medical School, King’s College London - Department of Twin Research and Genetic Epidemiology, King’s College London - Division of Biomedical Engineering and Imaging Sciences, King’s College London - Department of Twin Research and Genetic Epidemiology, University of Nottingham, University College London - Department of Infection, Harvard University - Harvard Medical School, Zoe Global Limited, King’s College London - Department of Twin Research and Genetic Epidemiology, King’s College London - School of Biomedical Engineering & Imaging Sciences and King's College London - Department of Twin Research and Genetic Epidemiology
Downloads 895 (66,054)

Abstract:

Loading...

COVID-19; vaccination; Phase IV trial; Pfizer-BioNTech; Oxford/AstraZeneca; BNT162b2; ChAdOx1 nCoV-19